Vitiligo showdown: new drug alone or with old favorites?
NCT ID NCT07368673
First seen Jan 26, 2026 · Last updated May 24, 2026 · Updated 18 times
Summary
This study tested whether a newer cream (ruxolitinib) works better alone or when combined with two older creams (tacrolimus and steroids) for vitiligo. 120 adults with small patches of vitiligo were treated for 24 weeks. The goal was to see which approach restores more skin color safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dow University of health sciences
Karachi, Sindh, Pakistan
Conditions
Explore the condition pages connected to this study.